source Post navigation At278 Ultra-Concentrated Ultra-Rapid Acting Insulin Demonstrates Superiority in Phase i Clinical Trial in Overweight … – GlobeNewswire Dexcom launches upgraded ONE+ device in UK – Medical Device Network